Biotech start-up that develops cancer immunotherapies OncoQR ML oncoqr.com

Biotech start-up that develops cancer immunotherapies OncoQR ML

Our vision is to defeat cancer. Our aim is to fully arm the patients immune system to successfully fight and thus win the battle against cancer.

history traffic contact

OVERVIEW

The site oncoqr.com currently has a traffic classification of zero (the lower the higher page views). We have downloaded six pages within the website oncoqr.com and found zero websites referencing oncoqr.com. We have detected two contacts and directions for oncoqr.com to help you reach them. The site oncoqr.com has been on the internet for six hundred and forty-four weeks, nine days, two hours, and forty minutes.

Pages Parsed

Contacts

Addresses

Online Since

Oct 2012

ONCOQR.COM TRAFFIC

The site oncoqr.com has seen fluctuating levels of traffic all over the year.

Date Range

1 week

1 month

3 months

This Year

Last Year

All time

Traffic ranking (by month) for oncoqr.com

Date Range

All time

This Year

Last Year

Traffic ranking by day of the week for oncoqr.com

Date Range

All time

This Year

Last Year

Last Month

ONCOQR.COM HISTORY

The site oncoqr.com was began on on October 19, 2012. This web site was last updated on the date of October 13, 2013. It will go back on the market on the date of October 19, 2014. It is currently six hundred and forty-four weeks, nine days, two hours, and forty minutes young.

REGISTERED

October

2012

UPDATED

October

2013

EXPIRED

October

2014

DOMAIN PERIOD

YEARS

MONTHS

DAYS

LINKS TO ONCOQR.COM

WHAT DOES ONCOQR.COM LOOK LIKE?

CONTACTS

OncoQR-ML

Christof Langer

Walterstrasse 21

Tullnerbach, 3011

43.6645160032

f4f86aa6nec@opensrs.namespace4you.com

Domainfactory GmbH

Hostmaster Domainfactory

Oskar-Messter-Str. 33

Ismaning, 85737

49.89552660

opensrs@namespace4you.com

ONCOQR.COM SERVER

We identified that the main root page on oncoqr.com took two thousand one hundred and seventy-two milliseconds to come up. We could not detect a SSL certificate, so our web crawlers consider oncoqr.com not secure.

Load time

2.172 sec

SSL

NOT SECURE

85.10.215.186

NAME SERVERS

ns.namespace4you.com

ns2.namespace4you.com

FAVICON

SERVER SOFTWARE

We detected that this domain is implementing the Apache os.

SITE TITLE

Biotech start-up that develops cancer immunotherapies OncoQR ML

DESCRIPTION

Our vision is to defeat cancer. Our aim is to fully arm the patients immune system to successfully fight and thus win the battle against cancer.

PARSED CONTENT

The site oncoqr.com had the following in the web page, "Our aim is to fully arm the patients immune system to fight and win the battle against cancer." I noticed that the webpage stated " Is available for licensing on a target-by-target basis." They also stated " Immunotherapy ACCI is capable of activating all 4 naturally available and evolutionary perfected tumor killing mechanisms in parallel. Lets join forces to win the fight against cancer! OncoQR ML was founded by two expe."

SEE MORE WEB SITES

Onco Quality Care - Empresa-OQC

Onco Quality Care, es un. CENTRO ESPECIALIZADO EN SERVICIOS INTEGRALES ONCOLOGICOS. Garantizando la oportuna y eficiente atención a pacientes con cáncer.

English United States Home

Turn off more accessible mode. Report a Downed Power Line. Request Temporary Removal of Meter. Request Temporary Removal of Meter.

rd2inc.com-This website is for sale!-rd2inc Resources and Information.

Is offering it for sale for an asking price of 499 USD! This webpage was generated by the domain owner using Sedo Domain Parking. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.

Dansk Forening for Onkoradiologi Danish Society of Oncoradiology

DRS Årsmøde Odense 24-26 januar. Referat fra bestyrelsesmøde 22 september 2017. Program for DFOR møde fredag d. 19 maj 2017, Roskilde Universitetshospital. Program Årsmøde DFOR 19 maj 2017. Årsmøde DFOR 19 maj 2017. Årsmøde i DFOR 19 maj 2017, Roskilde.